The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, …
Academic institutions have made significant investments to support public access to research data requirements, yet little to no data about these services, infrastructure, and costs currently exist or are widely shared. For public access to research …
On 10 February 2024, I gave a lightning talk at FOSDEM 2024's Open Research Online Devroom titled “Representing epistemological and disciplinary diversity in open research discourse”. It was informed by incredible feedback I received from various …
Bounded ethicality refers to people’s limited capacity to consistently behave in line with their ethical standards. Here, we present results from a pre-registered, large-scale (N = 11,050) survey of researchers in Sweden, suggesting that researchers …
Background: Despite wide recognition of the benefits of sharing research data, public availability rates have not increased substantially in oncology or medicine more broadly over the last decade. Methods: We surveyed 285 cancer researchers to …
The current movement toward open data and open science does not fully engage with Indigenous Peoples rights and interests. Existing principles within the open data movement (e.g. FAIR: findable, accessible, interoperable, reusable) primarily focus on …
Despite the progressive efforts of the Open Science movement to produce more internationally inclusive models of research and education, the Global North is still widely perceived as the center of knowledge, with countries from the Global South at …
A Harvard Medical School scientist who studies deadly brain tumors is facing accusations that more than two dozen papers he co-authored contain scientific images that appear doctored or copied.
The Dana-Farber Cancer Institute, a Harvard Medical School affiliate, is seeking to retract six studies and correct 31 other papers as part of a probe involving four of its senior cancer researchers and administrators.